The underlying mechanism of Nrf2 in obesity has been investigated using various experimental approaches, including Nrf2 gene deletion, Nrf2 pharmacological activators and Nrf2 gene overexpression, but only few of these approaches were clinically tested. The gene discussed is NFE2L2; the disease is obesity due to melanocortin 4 receptor deficiency.